Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-20-027496)

Filing Details

Accession Number:
0001209191-20-027496
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-06 16:43:43
Reporting Period:
2020-05-04
Accepted Time:
2020-05-06 16:43:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210		 Evp, Chief Patient Officer No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-04 32,500 $109.14 67,603 No 4 M Direct
Common Stock Acquisiton 2020-05-04 9,310 $131.89 76,913 No 4 M Direct
Common Stock Acquisiton 2020-05-04 1,942 $86.52 78,855 No 4 M Direct
Common Stock Disposition 2020-05-04 1,400 $258.59 77,455 No 4 S Direct
Common Stock Disposition 2020-05-04 6,223 $259.63 71,232 No 4 S Direct
Common Stock Disposition 2020-05-04 8,383 $260.48 62,849 No 4 S Direct
Common Stock Disposition 2020-05-04 4,395 $261.68 58,454 No 4 S Direct
Common Stock Disposition 2020-05-04 9,447 $262.69 49,007 No 4 S Direct
Common Stock Disposition 2020-05-04 964 $263.58 48,043 No 4 S Direct
Common Stock Disposition 2020-05-04 12,940 $264.92 35,103 No 4 S Direct
Common Stock Acquisiton 2020-05-05 13,356 $131.89 48,459 No 4 M Direct
Common Stock Disposition 2020-05-05 100 $265.72 48,359 No 4 S Direct
Common Stock Disposition 2020-05-05 300 $267.34 48,059 No 4 S Direct
Common Stock Disposition 2020-05-05 700 $269.08 47,359 No 4 S Direct
Common Stock Disposition 2020-05-05 11,553 $270.01 35,806 No 4 S Direct
Common Stock Disposition 2020-05-05 100 $271.09 35,706 No 4 S Direct
Common Stock Disposition 2020-05-05 403 $272.58 35,303 No 4 S Direct
Common Stock Disposition 2020-05-05 200 $273.59 35,103 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-05-04 32,500 $0.00 32,500 $109.14
Common Stock Stock Option (Right to Buy) Disposition 2020-05-04 9,310 $0.00 9,310 $131.89
Common Stock Stock Option (Right to Buy) Disposition 2020-05-04 1,942 $0.00 1,942 $86.52
Common Stock Stock Option (Right to Buy) Disposition 2020-05-05 13,356 $0.00 13,356 $131.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-02-02 No 4 M Direct
24,690 2025-07-20 No 4 M Direct
5,825 2027-02-02 No 4 M Direct
11,334 2025-07-20 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 882 Indirect 401(k)
Common Stock 14,002 Indirect GRAT
Footnotes
  1. Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $258.59 (range $258.00 to $258.97).
  3. Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $259.63 (range $259.03 to $260.02).
  5. Open market sales reported on this line occurred at a weighted average price of $260.48 (range $260.05 to $261.04).
  6. Open market sales reported on this line occurred at a weighted average price of $261.68 (range $261.14 to $262.13).
  7. Open market sales reported on this line occurred at a weighted average price of $262.69 (range $262.14 to $263.11).
  8. Open market sales reported on this line occurred at a weighted average price of $263.58 (range $263.17 to $264.02).
  9. Open market sales reported on this line occurred at a weighted average price of $264.92 (range $264.29 to $265.00).
  10. Open market sales reported on this line occurred at a weighted average price of $267.34 (range $267.11 to $267.67).
  11. Open market sales reported on this line occurred at a weighted average price of $269.08 (range $268.76 to $269.53).
  12. Open market sales reported on this line occurred at a weighted average price of $270.01 (range $269.98 to $270.87).
  13. Open market sales reported on this line occurred at a weighted average price of $272.58 (range $272.35 to $272.83).
  14. Open market sales reported on this line occurred at a weighted average price of $273.59 (range $273.50 to $273.67).
  15. Fully vested.
  16. The option vests in 16 quarterly installments from 02/03/2017.
Insider Monkey Quarterly Strategy
+275.3% Insider Monkey Quarterly Strategy
+125.2% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through May 20, 2024)